Emory University’s Myovant Sciences Ltd. MYOV Stock Holding History

Emory University’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-146,475	Closed	-$762K	–	15
2019 Q3	$762K	Sell	146,475 -31,513	-18%	-$234K	1.5%	14
2019 Q2	$1.61M	Buy	177,988 +66,063	+59%	+$985K	1.13%	41
2019 Q1	$2.67M	Sell	111,925 -12,226	-10%	-$250K	1.88%	11
2018 Q4	$2.04M	Sell	124,151 -2,649	-2%	-$52.2K	1.61%	21
2018 Q3	$3.37M	Buy	126,800 +3,745	+3%	+$84.8K	2.2%	4
2018 Q2	$2.81M	Sell	123,055 -53,332	-30%	-$1.16M	1.87%	14
2018 Q1	$3.75M	Buy	176,387 +45,024	+34%	+$685K	2.68%	3
2017 Q4	$1.66M	Sell	131,363 -25,940	-16%	-$348K	1.42%	39
2017 Q3	$2.43M	Buy	157,303 +28,075	+22%	+$341K	1.93%	4
2017 Q2	$1.51M	Buy	+129,228	New	+$1.6M	1.34%	40

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Emory University's MYOV Position: Q4 2019 in Review

Emory University sold out of Myovant Sciences Ltd. (MYOV) in Q4 2019, closing a stake of 146,475 shares — an estimated $762K sold.

Emory University first reported a position in MYOV in Q2 2017 and held it in 10 quarters. The position peaked at $3.75M in Q1 2018. 77 funds tracked by Wall St. Rank hold MYOV as of Q4 2019.

Emory University reported no remaining Myovant Sciences Ltd. position as of Q4 2019 after selling out during the quarter.
Emory University sold 146,475 Myovant Sciences Ltd. shares in Q4 2019, an estimated $762K.
Emory University first reported a position in Myovant Sciences Ltd. in Q2 2017 and held it in 10 quarters.
Emory University's Myovant Sciences Ltd. position peaked at $3.75M in Q1 2018.
77 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2019.

Based on Emory University's 13F filing for Q4 2019, filed 13 Feb 2020.